Skip to main contentSkip to navigation
Print subscriptions
Sign in
Search jobs
Search
The Guardian - Back to homeThe Guardian

Sanofi Genzyme MS

Read a report on a Guardian panel debate on the state of multiple sclerosis care and treatment in the UK sponsored by Sanofi Genzyme

July 2017

  • Patient entering Magnetic Resonance Imaging (MRI) scanner

    MS treatments: life-changing, but hard to access

    Therapies for multiple sclerosis are becoming more effective. But an underfunded NHS is struggling to provide timely diagnosis and make the latest treatments widely available
Explore more on these topics
  翻译：